Literature DB >> 25000459

Donor-recipient allele-level HLA matching of unrelated cord blood units reveals high degrees of mismatch and alters graft selection.

P B Dahi1, D M Ponce1, S Devlin2, K L Evans3, M Lubin3, A M Gonzales3, C Byam4, M Sideroff4, D Wells4, S Giralt1, N A Kernan4, A Scaradavou4, J N Barker1.   

Abstract

The feasibility of selecting cord blood (CB) units at high-resolution HLA match has not been investigated. We analyzed the high-resolution donor-recipient HLA match of 100 double-unit 4-6/6 HLA-A,-B antigen, -DRB1 allele-matched CB grafts (units 1a and 1b) and their back-up units (n=377 units in total). The median cryopreserved graft dose was 2.9 × 10(7)/kg/unit, and at high resolution these units had a median donor-recipient HLA-allele match of 5/8 (range 2-8/8) and 6/10 (range 2-9/10), respectively. We then evaluated how often use of high-resolution HLA-match criteria would change the original graft selection to substitute one or both of the back-up units for units 1a and/or 1b. On using a model in which both a higher eight-allele HLA match and a cell dose ⩾ 2.0 × 10(7)/kg/unit were required, graft selection changed in 33% of transplants with minimal effect on cell dose (8.3% reduction). In summary, while units chosen based on HLA-A,-B antigen and -DRB1 allele match have substantial mismatch at higher resolution, CB selection based on high-resolution HLA match is possible in a significant proportion of patients without compromise in cell dose.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25000459      PMCID: PMC4367540          DOI: 10.1038/bmt.2014.135

Source DB:  PubMed          Journal:  Bone Marrow Transplant        ISSN: 0268-3369            Impact factor:   5.483


  14 in total

1.  High-resolution HLA typing by sequencing for HLA-A, -B, -C, -DR, -DQ in 122 unrelated cord blood/patient pair transplants hardly improves long-term clinical outcome.

Authors:  G Kögler; J Enczmann; V Rocha; E Gluckman; P Wernet
Journal:  Bone Marrow Transplant       Date:  2005-12       Impact factor: 5.483

2.  HLA mismatch direction in cord blood transplantation: impact on outcome and implications for cord blood unit selection.

Authors:  Cladd E Stevens; Carmelita Carrier; Carol Carpenter; Dorothy Sung; Andromachi Scaradavou
Journal:  Blood       Date:  2011-07-12       Impact factor: 22.113

3.  Effect of donor-recipient HLA matching at HLA A, B, C, and DRB1 on outcomes after umbilical-cord blood transplantation for leukaemia and myelodysplastic syndrome: a retrospective analysis.

Authors:  Mary Eapen; John P Klein; Guillermo F Sanz; Stephen Spellman; Annalisa Ruggeri; Claudio Anasetti; Maria Brown; Richard E Champlin; Joan Garcia-Lopez; Gareth Hattersely; Gesine Koegler; Mary J Laughlin; Gerard Michel; Samir K Nabhan; Franklin O Smith; Mary M Horowitz; Eliane Gluckman; Vanderson Rocha
Journal:  Lancet Oncol       Date:  2011-10-06       Impact factor: 41.316

4.  Allogeneic hematopoietic cell transplantation for hematologic malignancy: relative risks and benefits of double umbilical cord blood.

Authors:  Claudio G Brunstein; Jonathan A Gutman; Daniel J Weisdorf; Ann E Woolfrey; Todd E Defor; Theodore A Gooley; Michael R Verneris; Frederick R Appelbaum; John E Wagner; Colleen Delaney
Journal:  Blood       Date:  2010-08-04       Impact factor: 22.113

5.  Reduced late mortality risk contributes to similar survival after double-unit cord blood transplantation compared with related and unrelated donor hematopoietic stem cell transplantation.

Authors:  Doris M Ponce; Junting Zheng; Anne Marie Gonzales; Marissa Lubin; Glenn Heller; Hugo Castro-Malaspina; Sergio Giralt; Katharine Hsu; Ann A Jakubowski; Robert R Jenq; Guenther Koehne; Esperanza B Papadopoulos; Miguel A Perales; Marcel R van den Brink; James W Young; Farid Boulad; Nancy A Kernan; Rachel Kobos; Susan Prockop; Andromachi Scaradavou; Trudy Small; Richard J O'Reilly; Juliet N Barker
Journal:  Biol Blood Marrow Transplant       Date:  2011-01-11       Impact factor: 5.742

Review 6.  How I treat: the selection and acquisition of unrelated cord blood grafts.

Authors:  Juliet N Barker; Courtney Byam; Andromachi Scaradavou
Journal:  Blood       Date:  2010-12-13       Impact factor: 22.113

7.  Effect of graft source on unrelated donor haemopoietic stem-cell transplantation in adults with acute leukaemia: a retrospective analysis.

Authors:  Mary Eapen; Vanderson Rocha; Guillermo Sanz; Andromachi Scaradavou; Mei-Jie Zhang; William Arcese; Anne Sirvent; Richard E Champlin; Nelson Chao; Adrian P Gee; Luis Isola; Mary J Laughlin; David I Marks; Samir Nabhan; Annalisa Ruggeri; Robert Soiffer; Mary M Horowitz; Eliane Gluckman; John E Wagner
Journal:  Lancet Oncol       Date:  2010-07       Impact factor: 41.316

8.  Outcomes of transplantation of unrelated donor umbilical cord blood and bone marrow in children with acute leukaemia: a comparison study.

Authors:  Mary Eapen; Pablo Rubinstein; Mei-Jie Zhang; Cladd Stevens; Joanne Kurtzberg; Andromachi Scaradavou; Fausto R Loberiza; Richard E Champlin; John P Klein; Mary M Horowitz; John E Wagner
Journal:  Lancet       Date:  2007-06-09       Impact factor: 79.321

9.  Impact of allele-level HLA matching on outcomes after myeloablative single unit umbilical cord blood transplantation for hematologic malignancy.

Authors:  Mary Eapen; John P Klein; Annalisa Ruggeri; Stephen Spellman; Stephanie J Lee; Claudio Anasetti; William Arcese; Juliet N Barker; Lee Ann Baxter-Lowe; Maria Brown; Marcelo A Fernandez-Vina; John Freeman; Wensheng He; Anna Paola Iori; Mary M Horowitz; Franco Locatelli; Susana Marino; Martin Maiers; Gerard Michel; Guillermo F Sanz; Eliane Gluckman; Vanderson Rocha
Journal:  Blood       Date:  2013-10-18       Impact factor: 22.113

10.  Results of the Cord Blood Transplantation Study (COBLT): clinical outcomes of unrelated donor umbilical cord blood transplantation in pediatric patients with hematologic malignancies.

Authors:  Joanne Kurtzberg; Vinod K Prasad; Shelly L Carter; John E Wagner; Lee Ann Baxter-Lowe; Donna Wall; Neena Kapoor; Eva C Guinan; Stephen A Feig; Elizabeth L Wagner; Nancy A Kernan
Journal:  Blood       Date:  2008-08-21       Impact factor: 22.113

View more
  7 in total

Review 1.  Optimal Practices in Unrelated Donor Cord Blood Transplantation for Hematologic Malignancies.

Authors:  Juliet N Barker; Joanne Kurtzberg; Karen Ballen; Michael Boo; Claudio Brunstein; Corey Cutler; Mitchell Horwitz; Filippo Milano; Amanda Olson; Stephen Spellman; John E Wagner; Colleen Delaney; Elizabeth Shpall
Journal:  Biol Blood Marrow Transplant       Date:  2017-03-06       Impact factor: 5.742

2.  High day 28 ST2 levels predict for acute graft-versus-host disease and transplant-related mortality after cord blood transplantation.

Authors:  Doris M Ponce; Patrick Hilden; Christen Mumaw; Sean M Devlin; Marissa Lubin; Sergio Giralt; Jenna D Goldberg; Alan Hanash; Katharine Hsu; Robert Jenq; Miguel-Angel Perales; Craig Sauter; Marcel R M van den Brink; James W Young; Renier Brentjens; Nancy A Kernan; Susan E Prockop; Richard J O'Reilly; Andromachi Scaradavou; Sophie Paczesny; Juliet N Barker
Journal:  Blood       Date:  2014-11-06       Impact factor: 22.113

3.  Better allele-level matching improves transplant-related mortality after double cord blood transplantation.

Authors:  Betül Oran; Kai Cao; Rima M Saliba; Katayoun Rezvani; Marcos de Lima; Sairah Ahmed; Chitra M Hosing; Uday R Popat; Yudith Carmazzi; Partow Kebriaei; Yago Nieto; Gabriela Rondon; Dana Willis; Nina Shah; Simrit Parmar; Amanda Olson; Brandt Moore; David Marin; Rohtesh Mehta; Marcelo Fernández-Viña; Richard E Champlin; Elizabeth J Shpall
Journal:  Haematologica       Date:  2015-08-06       Impact factor: 9.941

4.  High Disease-Free Survival with Enhanced Protection against Relapse after Double-Unit Cord Blood Transplantation When Compared with T Cell-Depleted Unrelated Donor Transplantation in Patients with Acute Leukemia and Chronic Myelogenous Leukemia.

Authors:  Doris M Ponce; Patrick Hilden; Sean M Devlin; Molly Maloy; Marissa Lubin; Hugo Castro-Malaspina; Parastoo Dahi; Katharine Hsu; Ann A Jakubowski; Nancy A Kernan; Guenther Koehne; Richard J O'Reilly; Esperanza B Papadopoulos; Miguel-Angel Perales; Craig Sauter; Andromachi Scaradavou; Roni Tamari; Marcel R M van den Brink; James W Young; Sergio Giralt; Juliet N Barker
Journal:  Biol Blood Marrow Transplant       Date:  2015-07-31       Impact factor: 5.742

5.  Rare variant discovery by deep whole-genome sequencing of 1,070 Japanese individuals.

Authors:  Masao Nagasaki; Jun Yasuda; Fumiki Katsuoka; Naoki Nariai; Kaname Kojima; Yosuke Kawai; Yumi Yamaguchi-Kabata; Junji Yokozawa; Inaho Danjoh; Sakae Saito; Yukuto Sato; Takahiro Mimori; Kaoru Tsuda; Rumiko Saito; Xiaoqing Pan; Satoshi Nishikawa; Shin Ito; Yoko Kuroki; Osamu Tanabe; Nobuo Fuse; Shinichi Kuriyama; Hideyasu Kiyomoto; Atsushi Hozawa; Naoko Minegishi; James Douglas Engel; Kengo Kinoshita; Shigeo Kure; Nobuo Yaegashi; Masayuki Yamamoto
Journal:  Nat Commun       Date:  2015-08-21       Impact factor: 14.919

6.  The effect of inter-unit HLA matching in double umbilical cord blood transplantation for acute leukemia.

Authors:  Claudio Brunstein; Mei-Jie Zhang; Juliet Barker; Andrew St Martin; Asad Bashey; Marcos de Lima; Jason Dehn; Peiman Hematti; Miguel-Angel Perales; Vanderson Rocha; Mary Territo; Daniel Weisdorf; Mary Eapen
Journal:  Haematologica       Date:  2017-01-25       Impact factor: 9.941

Review 7.  Is There Any Reason to Prefer Cord Blood Instead of Adult Donors for Hematopoietic Stem Cell Transplants?

Authors:  Meral Beksac
Journal:  Front Med (Lausanne)       Date:  2016-01-11
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.